UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000049574
Receipt number R000056459
Scientific Title The prevalence of obstructive sleep apnea in patients with chronic obstructive pulmonary disease: meta-analysis
Date of disclosure of the study information 2022/11/21
Last modified on 2022/11/21 16:11:33

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The prevalence of obstructive sleep apnea in patients with chronic obstructive pulmonary disease: meta-analysis

Acronym

The prevalence of obstructive sleep apnea in patients with chronic obstructive pulmonary disease: meta-analysis

Scientific Title

The prevalence of obstructive sleep apnea in patients with chronic obstructive pulmonary disease: meta-analysis

Scientific Title:Acronym

The prevalence of obstructive sleep apnea in patients with chronic obstructive pulmonary disease: meta-analysis

Region

Japan


Condition

Condition

COPD
OSA

Classification by specialty

Pneumology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To estimate the global prevalence of OSA in COPD patients

Basic objectives2

Others

Basic objectives -Others

prevalence

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

prevalence

Key secondary outcomes



Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

The studies of OS written in English are collected. The prevalence of OS in COPD patients must be described. COPD patients must be diagnosed with spirometry and confirmed by the presence of a postbronchodilator forced expiratory volume in the 1st second/forced vital capacity (FEV1/FVC) < 70%. And OSA must be diagnosed according to AHI of PSG.

Key exclusion criteria

Non-English studies are not collected.

Target sample size



Research contact person

Name of lead principal investigator

1st name Nobuhiko
Middle name
Last name Fukuda

Organization

Yokohama City University Graduate School of Medicine, Yokohama, Japan

Division name

Department of Pulmonology

Zip code

236-0004

Address

Fukuura 3-9 Kanazawa-Ku, Yokohama, Kanagawa, Japan

TEL

0457872800

Email

e103066f@yokohama-cu.ac.jp


Public contact

Name of contact person

1st name Nobuhiko
Middle name
Last name Fukuda

Organization

Yokohama City University Graduate School of Medicine, Yokohama, Japan

Division name

Department of Pulmonology

Zip code

236-0004

Address

Fukuura 3-9 Kanazawa-Ku, Yokohama, Kanagawa, Japan

TEL

0457872800

Homepage URL


Email

e103066f@yokohama-cu.ac.jp


Sponsor or person

Institute

Yokohama City University

Institute

Department

Personal name



Funding Source

Organization

Yokohama City University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Yokohama City University

Address

Fukuura 3-9 Kanazawa-Ku, Yokohama, Kanagawa, Japan

Tel

0457872800

Email

e103066f@yokohama-cu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 11 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2022 Year 08 Month 18 Day

Date of IRB

2022 Year 08 Month 18 Day

Anticipated trial start date

2022 Year 08 Month 18 Day

Last follow-up date

2022 Year 08 Month 18 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Study search
Pubmed will be searched to identify eligible articles on August, 2022. The retrieval formula is as follows:

Pubmed
(COPD OR chronic obstructive pulmonary disease) AND (sleep apnea OR OSA OR SAS) AND (COPD[Title] OR chronic obstructive pulmonary disease[Title] OR sleep apnea[Title] OR OSA[Title] OR SAS[Title]) AND (prevalence OR epidemiology OR epidemiological OR epidemiologic OR population)

Web of Science
TI=(COPD OR chronic obstructive pulmonary disease OR sleep apnea OR OSA OR SAS)
AND
TS=(COPD OR chronic obstructive pulmonary disease)
AND
TS=(sleep apnea OR OSA OR SAS)
AND
TS=(prevalence OR epidemiology OR epidemiological OR epidemiologic OR population)

Data extraction
The characteristics (first author name, publication year, country, methods of diagnosis, gender, age, body mass index (BMI), spirometry date and sample size) of including studies and trial outcome with its 95% confidence interval (95% CI) are extracted by two authors (SM and NF). The extracted data is checked by two authors and final confirmation was done by a third author (NH).

Statistical analyses
The frequentist weighted least squares approach random-model network meta-analysis will be applied in our study8). Data are analyzed using Review Manager 5 software.


Management information

Registered date

2022 Year 11 Month 21 Day

Last modified on

2022 Year 11 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056459